A prospective study of positive/negative ex vivo B-cell depletion in patients with chronic lymphocytic leukemia

Experimental Hematology

Volumn 28, Issue 10, 2000, Pages 1187-1196

  Dreger, Peter ^a   Viehmann, Karin ^a   Von Neuhoff, Nils ^a   Krüss, Daniela ^a   Glass, Bertram ^a   Kneba, Michael ^a   Mitsky, Peggie ^b   Jopp, Petra ^c   Rautenberg, Peter ^a   Mills, Bonnie ^b   Schmitz, Norbert ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b Nexell Therapeutics Inc   (United States)

^c Baxter GmbH   (Germany)

Author keywords

CD34+ selection; CLL; Immunomagnetic; PBSC; Purging

Indexed keywords

ACICLOVIR; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CARMUSTINE; CD19 ANTIGEN; CD34 ANTIGEN; CD5 ANTIGEN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; MELPHALAN; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; DRUG MEGADOSE; HUMAN; INFECTIOUS COMPLICATION; LUNG TOXICITY; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR CELL; VIRUS INFECTION;

ADULT; ANTIGENS, CD34; B-LYMPHOCYTES; BLOOD COMPONENT REMOVAL; FEASIBILITY STUDIES; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMAGNETIC SEPARATION; INFECTION; LEUKAPHERESIS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGE; PROGNOSIS; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; TREATMENT OUTCOME;

EID: 0033797472     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(00)00524-5     Document Type: Article

References (32)

1. Dreger P., von Neuhoff N., Suttorp M., Schmitz N. Rapid engraftment of peripheral blood progenitor cell grafts purged with B cell-specific monoclonal antibodies and immunomagnetic beads. Bone Marrow Transplant. 16:1995;627.
2. Itälä M., Pelliniemi T.-T., Rajamäki A., Remes K. Autologous blood cell transplantation in B-CLL. response to chemotherapy prior to mobilization predicts the stem cell yield Bone Marrow Transplant. 19:1997;647.
3. Dreger P., Viehmann K., von Neuhoff N.et al. Autografting of highly purified peripheral blood progenitor cell following myeloablative therapy in patients with lymphoma. a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery Bone Marrow Transplant. 24:1999;153.
4. Paulus U., Schmitz N., Viehmann K., von Neuhoff N., Dreger P. Combined positive/negative selection for highly effective purging of PBPC grafts. towards clinical application in patients with B-CLL Bone Marrow Transplant. 20:1997;415.
5. Stansfield A., Diebold J., Kapanci Y.et al. Updated Kiel classification for lymphoma. Lancet i: 292:1988.
6. Harris N.L., Jaffe E.S., Stein H.et al. A revised European-American classification of lymphoid neoplasms. a proposal from the International Lymphoma Study Group Blood. 84:1994;1361.
7. Hiddemann W., Longo D.L., Coiffier B.et al. Lymphoma classification - the gap between biology and clinical management is closing. Blood. 88:1996;4085.
8. Hallek M., Langenmayer I., Nerl C.et al. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood. 93:1999;1732.
9. Dreger P., Marquardt P., Haferlach T.et al. Effective mobilisation of peripheral blood progenitor cells with "Dexa-BEAM" and G-CSF. timing of harvesting and composition of the leukapheresis product Br J Cancer. 68:1993;950.
10. von Neuhoff N., Dreger P., Suttorp M., Marget M., Kell S., Schmitz N. Comparison of different strategies of molecular genetic monitoring following autologous stem cell transplantation in patients with follicular lymphoma. Bone Marrow Transplant. 22:1998;161.
11. Dreger P., Glass B., Kuse R.et al. Myeloablative radiochemotherapy followed by reinfusion of purged autologous stem cells for Waldenström's macroglobulinaemia. Br J Haematol. 106:1999;115.
12. Dreger P., Rautenberg P., Kneba M., Schmitz N. Hepatitis B viremia in a patient with documented previous HBV immunity after autologous transplantation of highly purified PBSC. Bone Marrow Transplant. 26:2000;114.
13. Michallet M., Carreras E., Cornelissen J.J.et al. Allotransplants and autotransplants in CLL. Bone Marrow Transplant. 23(Suppl 1):1999;S53. [Abstract].
14. Montserrat E., Esteve J., Schmitz N.et al. Autologous stem cell transplantation for CLL. analysis of the impact on overall survival in 107 patients from The International Project for CLL/transplants Blood. 94(Suppl 1):1999;397a.
15. Milligan D.W., Davies F.E., Morgan G.J., Child J.A., Catovsky D. Fludarabine followed by stem cell autografting for younger patients with CLL. preliminary results from the MRC pilot study Bone Marrow Transplant. 23(Suppl 1):1999;S53. [Abstract].
16. Dreger P., Döhner H., Emmerich B.et al. A prospective multicenter study on early autologous stem cell transplantation in CLL (CLL3-Study). first interim analysis Bone Marrow Transplant. 25(Suppl 1):2000;S9. [Abstract].
17. Donnovan J.W., Andersen N.S., Poor C.M., Bowers D., Gribben J.G. Prospective analysis of minimal residual disease detection in patients with CLL undergoing autologous and allogeneic BMT. Blood. 92:1998;652a. [Abstract].
18. Handretinger R., Lang P., Schumm M.et al. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnet-activated cell sorting. Bone Marrow Transplant. 21:1998;987.
19. Martin-Henao G.A., Picon M., Amill B.et al. Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system. factors affecting the results Transfusion. 40:2000;35.
20. Gahn B., Wendenburg B., Troff C.et al. Analysis of progenitor cell involvement in B-CLL by simultaneous immunophenotypic and genotypic analysis at the single cell level. Br J Haematol. 105:1999;955.
21. Paulus U., Dreger P., Viehmann K., von Neuhoff N., Schmitz N. Purging peripheral blood progenitor cell grafts from lymphoma cells. quantitative comparison of immunomagnetic CD34+ selection systems Stem Cells. 15:1997;297.
22. Gorin N.-C., Lopez M., Laporte J.-P.et al. Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with Non-Hodgkin's lymphoma. Blood. 85:1995;1647.
23. Provan D., Bartlett-Pandite L., Zwicky C.et al. Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation. Blood. 88:1996;2228.
24. Kvalheim G., Sörensen O., Fodstad Öet al. Immunomagnetic removal of B-lymphoma cells from human bone marrow. a procedure for clinical use Bone Marrow Transplant. 3:1988;31.
25. Brugger W, Manz M, Grünebach F, Rösler W, Scheding S, Kanz L (1999) A pilot study of anti-CD20 rituximab treatment after high-dose therapy and CD34+ blood stem cell transplantation for newly diagnosed follicular non-Hodgkin's lymphoma [abstract]. Haematologica 84:PO-0628.
26. Schmitz N., Diehl V. Carmustine and the lungs. Lancet. 349:1997;1712.
27. Bilgrami S., Chakraborty N.G., Rodriguez-Pinero F.et al. Varicella zoster virus infection associated with high-dose chemotherapy and autologous stem-cell rescue. Bone Marrow Transplant. 23:1999;469.
28. Schulenburg A., Kalhs P., Worel N., Hocker P., Knobl P., Greinix H.T. Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases. Bone Marrow Transplant. 25:2000;223.
29. Holmberg L.A., Boeckh M., Hooper H.et al. Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood. 94:1999;4029.
30. Hakim F.T., Cepeda R., Kaimei S.et al. Constraints on CD4 recovery postchemotherapy in adults. thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells Blood. 90:1997;3789.
31. Roux E., Helg C., Dumont G.F., Chapuis B., Jeannet M., Roosnek E. Analysis of T-cell repopulation after allogeneic bone marrow transplantation. significant differences between recipients of T-cell depleted and unmanipulated grafts Blood. 87:1996;3984.
32. Bomberger C., Singh-Jairam M., Rodey G.et al. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood. 91:1998;2588.